Dewpoint Therapeutics
Biotechnology ResearchView the employees at
Dewpoint Therapeutics-
Scott Peterson Senior Vice President, Corporate Development at Dewpoint Therapeutics
-
Salem, Massachusetts, United States
-
Rising Star
Han Chen Biochemist and virologist with expertise in early drug discovery for small molecule therapeutics-
Boston, Massachusetts, United States
-
Rising Star
Crystal McKinnon Scientist, Screening and Automation-
Top 10%
Mégane Valero Senior Scientist in Medicinal Chemistry at Dewpoint Therapeutics-
Frankfurt, Hesse, Germany
-
Rising Star
Malik Faraj Research associate at Dewpoint Therapeutics-
Boston, Massachusetts, United States
-
Rising Star
Overview
Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.
-